Linfang Li
-
- Virus-based gene therapy research 14
-
- MicroRNA in disease regulation 4
-
- Cancer Research and Treatments 7
-
- CAR-T cell therapy research 5
-
- Viral Infectious Diseases and Gene Expression in Insects 4
- RNA Interference and Gene Delivery 4
- Extracellular vesicles in disease 2
-
- Viral gastroenteritis research and epidemiology 2
- Cited by
- GeneticsCancer ResearchBiotechnology
- Partner nations
- ChinaSwedenUnited States
In The Last Decade
Linfang Li
20 papers receiving 377 citations
Peers
Comparison fields: 5 of 60
- Genetics 159
- Cancer Research 77
- Biotechnology 43
- Oncology 116
- Molecular Biology 218
Countries citing papers authored by Linfang Li
This map shows the geographic impact of Linfang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linfang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linfang Li more than expected).
Fields of papers citing papers by Linfang Li
This network shows the impact of papers produced by Linfang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linfang Li. The network helps show where Linfang Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Linfang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2021 | 23 | |
| 5 | ER-α36 mediates gastric cancer cell invasion. | 2020 | 5 |
| 6 | 2018 | 11 | |
| 7 | 2017 | 9 | |
| 8 | 2016 | 10 | |
| 9 | 2015 | 37 | |
| 10 | 2013 | 9 | |
| 11 | 2012 | 31 | |
| 12 | 2012 | 27 | |
| 13 | 2011 | 47 | |
| 14 | 2010 | 29 | |
| 15 | [Synergistic killing effect of the conditionally replicating adenoviruses carrying programmed cell death 5 gene and etoposide on K562 cells]. | 2010 | 1 |
| 16 | 2009 | 19 | |
| 17 | 2009 | 19 | |
| 18 | 2009 | 3 | |
| 19 | 2008 | 25 | |
| 20 | [Gene therapy for ovarian cancers by adenovirus-mediated complete antibody gene]. | 2004 | 5 |
About Linfang Li
Linfang Li is a scholar working on Biotechnology, Genetics and Cancer Research, having authored 22 papers that have together received 382 indexed citations. Recurring topics across this work include Virus-based gene therapy research (14 papers), Cancer Research and Treatments (7 papers), CAR-T cell therapy research (5 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers), RNA Interference and Gene Delivery (4 papers), MicroRNA in disease regulation (4 papers), Viral gastroenteritis research and epidemiology (2 papers) and Extracellular vesicles in disease (2 papers). The work is most often cited by research in Genetics (159 citations), Cancer Research (77 citations) and Biotechnology (43 citations). Linfang Li has collaborated with scholars based in China, Sweden and United States. Frequent co-authors include Qijun Qian, Huajun Jin, Mengchao Wu, Changqing Su, Yao Huang, Hongping Wu, Xinyuan Liu, Wei Ji, Yukihiro Ozaki and Jianzhang Zhao.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.